DarioHealth Corp (DRIO)
NASDAQ:DRIO
Total Valuation
DarioHealth has a market cap or net worth of $46.50M. The enterprise value is $52.01M.
Market Cap$46.50M
Enterprise Value$52.01M
Share Statistics
DarioHealth has 7,300,406 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding7,300,406
Owned by Insiders7.92%
Owned by Institutions8.34%
Financial Efficiency
DarioHealth’s return on equity (ROE) is -0.61 and return on invested capital (ROIC) is -36.23%.
Return on Equity (ROE)-0.61
Return on Assets (ROA)-0.38
Return on Invested Capital (ROIC)-36.23%
Return on Capital Employed (ROCE)-0.36
Revenue Per Employee114.08K
Profits Per Employee-212.83K
Employee Count196
Asset Turnover0.20
Inventory Turnover2.25
Valuation Ratios
The current PE Ratio of DarioHealth is ―. DarioHealth’s PEG ratio is 0.05.
PE Ratio―
PS Ratio25.26
PB Ratio8.32
Price to Fair Value8.32
Price to FCF-21.65
Price to Operating Cash Flow-12.19
PEG Ratio0.05
Income Statement
In the last 12 months, DarioHealth had revenue of 22.36M and earned -41.71M in profits. Earnings per share was 1.24.
Revenue22.36M
Gross Profit12.66M
Operating Income-36.66M
Pretax Income-41.61M
Net Income-41.71M
EBITDA-33.10M
Earnings Per Share (EPS)1.24
Cash Flow
In the last 12 months, operating cash flow was -25.94M and capital expenditures -142.00K, giving a free cash flow of -26.08M billion.
Operating Cash Flow-25.94M
Free Cash Flow-26.08M
Free Cash Flow per Share-3.57
Dividends & Yields
DarioHealth pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.92
52-Week Price Change-43.93%
50-Day Moving Average9.73
200-Day Moving Average11.57
Relative Strength Index (RSI)29.34
Average Volume (3m)33.32K
Important Dates
DarioHealth upcoming earnings date is May 20, 2026, Before Open (Confirmed).
Last Earnings DateMar 19, 2026
Next Earnings DateMay 20, 2026
Ex-Dividend Date―
Financial Position
DarioHealth as a current ratio of 3.73, with Debt / Equity ratio of 46.74%
Current Ratio3.73
Quick Ratio3.27
Debt to Market Cap0.06
Net Debt to EBITDA-0.17
Interest Coverage Ratio-10.91
Taxes
In the past 12 months, DarioHealth has paid 105.00K in taxes.
Income Tax105.00K
Effective Tax Rate>-0.01
Enterprise Valuation
DarioHealth EV to EBITDA ratio is -17.23, with an EV/FCF ratio of -21.86.
EV to Sales25.51
EV to EBITDA-17.23
EV to Free Cash Flow-21.86
EV to Operating Cash Flow-21.98
Balance Sheet
DarioHealth has $26.25M in cash and marketable securities with $31.75M in debt, giving a net cash position of -$5.50M billion.
Cash & Marketable Securities$26.25M
Total Debt$31.75M
Net Cash-$5.50M
Net Cash Per Share-$0.75
Tangible Book Value Per Share-$0.11
Margins
Gross margin is 56.64%, with operating margin of -163.94%, and net profit margin of -186.56%.
Gross Margin56.64%
Operating Margin-163.94%
Pretax Margin-186.10%
Net Profit Margin-186.56%
EBITDA Margin-148.02%
EBIT Margin-163.94%
Analyst Forecast
The average price target for DarioHealth is $10.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$10.50
Price Target Upside-10.41% Downside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast7.29%
EPS Growth Forecast7.24%